Cidara Therapeutics, Inc.CDTXNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-103.51%
↓ 110% below average
Average (9y)
-49.30%
Historical baseline
Range
High:-11.48%
Low:-103.51%
CAGR
+27.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -103.51% | -213.3% |
| 2023 | -33.04% | +38.9% |
| 2022 | -54.10% | -42.5% |
| 2021 | -37.96% | +42.2% |
| 2020 | -65.69% | -164.3% |
| 2019 | -24.85% | +73.4% |
| 2018 | -93.56% | -121.7% |
| 2017 | -42.20% | -58.3% |
| 2016 | -26.66% | -132.2% |
| 2015 | -11.48% | - |